Algernon Pharmaceuticals Inc (AGNPF)

[tcm7]

"The immediate future is focussed around securing the resources required to conduct a minimum of 2 phase II trials, and then focussing on getting the compounds in the clinic and the trials started", "then first patient enrolment".

My suggestion stands as a way to finance all this, "selling the BTH rights to the POC device to any interested party".,. Another is for a partnership which would be the ideal method. The least favorable would be dilution thru an offering or debt, especially at these lower prices per share.
Did I miss this financing part's answer?